Table 3.
Diagnosis | SSRI/SNRI | Benzodiazepine | Atypical antipsychotics | |||
---|---|---|---|---|---|---|
Women | Men | Women | Men | Women | Men | |
OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
Demographics | ||||||
Age group, years | ||||||
<30 | 0.80 | 0.85 | 0.59 | 0.78 | 0.58 | 0.66 |
(0.75, 0.86) | (0.82, 0.87) | (0.55, 0.64) | (0.75, 0.80) | (0.54, 0.63) | (0.64, 0.69) | |
30–39 | 0.96 | 1.01 | 0.78 | 0.93 | 0.81 | 0.89 |
(0.89, 1.02) | (0.98, 1.04) | (0.73, 0.83) | (0.90, 0.96) | (0.75, 0.87) | (0.86, 0.92) | |
40–49 | Reference | Reference | Reference | Reference | Reference | Reference |
50–64 | 1.02 | 0.96 | 1.01 | 1.00 | 0.85 | 0.87 |
(0.96, 1.09) | (0.93, 0.99) | (0.95, 1.07) | (0.96, 1.03) | (0.79, 0.90) | (0.84, 0.90) | |
≥65 | 0.88 | 0.85 | 0.84 | 0.86 | 0.36 | 0.59 |
(0.72, 1.06) | (0.81, 0.88) | (0.70, 1.01) | (0.83, 0.90) | (0.28, 0.47) | (0.57, 0.62) | |
Urban residence | 0.90 | 0.88 | 0.90 | 0.86 | 0.94 | 0.95 |
(0.85, 0.95) | (0.86, 0.89) | (0.85, 0.95) | (0.84, 0.87) | (0.88, 0.99) | (0.94, 0.97) | |
Service connection >50 % | 1.26 | 1.29 | 1.47 | 1.46 | 1.28 | 1.19 |
(1.20, 1.32) | (1.27, 1.31) | (1.40, 1.54) | (1.43, 1.48) | (1.22, 1.35) | (1.17, 1.21) | |
Service era | ||||||
Pre-Vietnam | 0.70 | 0.80 | 0.92 | 1.07 | 0.98 | 0.80 |
(0.54, 0.92) | (0.77, 0.82) | (0.71, 1.20) | (1.03, 1.11) | (0.68, 1.42) | (0.77, 0.84) | |
Vietnam | Reference | Reference | Reference | Reference | Reference | Reference |
Post-Vietnam | 0.89 | 1.00 | 0.82 | 0.92 | 0.96 | 1.32 |
(0.82, 0.97) | (0.98, 1.03) | (0.76, 0.89) | (0.90, 0.95) | (0.88, 1.04) | (1.28, 1.36) | |
PTSD dx duration in VA | ||||||
New diagnosis | 0.76 | 0.69 | 0.63 | 0.53 | 0.58 | 0.47 |
(0.71, 0.80) | (0.68, 0.70) | (0.59, 0.67) | (0.52, 0.54) | (0.54, 0.62) | (0.46, 0.48) | |
1–2 years | 1.06 | 0.98 | 0.80 | 0.73 | 0.84 | 0.70 |
(1.00, 1.13) | (0.96, 0.99) | (0.76, 0.85) | (0.72, 0.74) | (0.79, 0.89) | (0.69, 0.72) | |
3+ years | Reference | Reference | Reference | Reference | Reference | Reference |
Comorbidity | ||||||
Depressive disorder | 2.88 | 2.61 | 1.36 | 1.41 | 1.04 | 1.43 |
(2.75, 3.01) | (2.58, 2.64) | (1.30, 1.42) | (1.39, 1.43) | (0.99, 1.10) | (1.41, 1.45) | |
Panic disorder | 1.72 | 1.71 | 3.48 | 4.51 | 1.31 | 1.55 |
(1.57, 1.89) | (1.65, 1.77) | (3.21, 3.78) | (4.36, 4.67) | (1.21, 1.42) | (1.50, 1.61) | |
GAD | 1.31 | 1.41 | 1.92 | 2.46 | 1.12 | 1.30 |
(1.19, 1.45) | (1.36, 1.46) | (1.75, 2.10) | (2.38, 2.54) | (1.02, 1.24) | (1.26, 1.35) | |
OCD | 1.65 | 1.88 | 1.53 | 1.62 | 2.14 | 2.29 |
(1.37, 1.99) | (1.72, 2.05) | (1.30, 1.80) | (1.50, 1.74) | (1.82, 2.51) | (2.12, 2.46) | |
Social phobia | 1.44 | 1.61 | 1.30 | 1.58 | 1.20 | 1.34 |
(0.97, 2.13) | (1.40, 1.84) | (0.93, 1.81) | (1.40, 1.78) | (0.85, 1.70) | (1.19, 1.52) | |
Substance use disorder | 1.29 | 1.10 | 1.11 | 0.92 | 2.71 | 1.92 |
(1.22, 1.37) | (1.08, 1.11) | (1.05, 1.18) | (0.90, 0.93) | (2.56, 2.87) | (1.89, 1.95) | |
Traumatic brain injury | 1.00 | 1.16 | 1.23 | 1.32 | 1.14 | 1.21 |
(0.88, 1.13) | (1.12, 1.20) | (1.09, 1.39) | (1.27, 1.36) | (1.00, 1.30) | (1.17, 1.25) |
Each column is a separate multiple logistic regression model